Core-003
Core-003
批准号:
10662364
负责人:
Sallie R. Permar
金额:
$30.18万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-07-24 至 2025-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – Genomic Sequencing and Population Genetics Core – Core 3
The Genomic Sequencing and Population Genetics Core (Core 3) supports the Program’s two projects in
evaluating and understanding the relationship between cCMV genetic variation, transmission, and immune
response. The Core is responsive to the understanding that herpes viruses, and human cytomegalovirus
(HCMV) in particular, are large DNA viruses that exhibit surprising levels of sequence diversity: HCMV
samples from patients often have 1,000’s polymorphisms at both the consensus and population levels. This
level of standing genetic variation is biologically important, as it has been shown to play a significant role in a
range of clinical infectious disease challenges. For example, in HCMV, genetic diversity contributes to temporal
and compartmental changes in allele frequencies in congenital fetal infections. To support investigations of
such dynamics in our RhCMV model, the Genomic Sequencing Core will sequence populations of RhCMV
genomes from animals, inoculum, and cultured virus samples provided by Projects 1-2 (Aim 1). Sequence
reads will be mapped as RhCMV sequences through an iterative process of reference mediated alignments
and de novo contig builds. RhCMV sequence datasets will be used to define an annotated consensus (i.e., the
most common) sequence of each sample and provide summary statistics of viral populations. Summary
statistics include total number of sequences reads, mapped reads/efficiency, mean coverage, polymorphisms
in the consensus relative to the parental virus and population diversity. Results will be made available to the
Projects. In addition, the Core will improve workflow by cataloguing an RhCMV saturation dataset, improve
processing protocols, and will collaborate with the Viral Pathogen and Analysis Resource (ViPR) to provide
RhCMV sequence data and related in vivo data for their simple, searchable format (Aim 2). Bulk sequence
data will be submitted to the publicly available NCBI Sequence Read Archive. Finally, the Core will employ
population genetics strategies to investigate the patterns of RhCMV evolution in congenital RhCMV models by
interrogating viral loads and viral population sequence space to define diversity and mechanisms of divergence
amongst maternal and infant viral populations (Aim 3). Other parameters that influence infection, transmission
and disease including viral gene deletion strains (Project 2) and altered immunological states (Project 1) will
be analyzed for their influence on viral population diversity, founder size and compartmental effects in relation
to transmission and disease. Taken together, the Core will provide important understanding of how in vivo
evolutionary processes, such as bottlenecks and selective pressure, influence viral transmission and fetal
disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
-
批准号:10677439
-
项目类别:
-
资助金额:$84.84万
-
财政年份:2023
-
负责人:Sallie R. Permar
-
依托单位:
Pediatric Scientist Development Program
-
批准号:10619351
-
项目类别:
-
资助金额:$153.57万
-
财政年份:2022
-
负责人:Sallie R. Permar
-
依托单位:
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
-
批准号:10327003
-
项目类别:
-
资助金额:$74.42万
-
财政年份:2021
-
负责人:Sallie R. Permar
-
依托单位:
Pediatric Scientist Development Program
-
批准号:10349771
-
项目类别:
-
资助金额:$87.5万
-
财政年份:2020
-
负责人:Sallie R. Permar
-
依托单位:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
-
批准号:10223633
-
项目类别:
-
资助金额:$13.75万
-
财政年份:2020
-
负责人:Sallie R. Permar
-
依托单位:
Pediatric Scientist Development Program
-
批准号:10220089
-
项目类别:
-
资助金额:$140.96万
-
财政年份:2020
-
负责人:Sallie R. Permar
-
依托单位:
Project-003
-
批准号:10461206
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core-001
-
批准号:10461201
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Project-003
-
批准号:10441007
-
项目类别:
-
资助金额:$25.81万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core-004
-
批准号:10441005
-
项目类别:
-
资助金额:$16.83万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Project 1: Immune correlates of cCMV
-
批准号:10215784
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core 2: Virology, Molecular, and Histology Core
-
批准号:10215781
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core 3: Genomic Sequencing and Population Genetics Core
-
批准号:10215782
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Immunologic and virologic determinants of congenital Cytomegalovirus transmission and disease in rhesus monkeys
-
批准号:10402416
-
项目类别:
-
资助金额:$294.82万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core 3: Genomic Sequencing and Population Genetics Core
-
批准号:10374246
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core 2: Virology, Molecular, and Histology Core
-
批准号:10374245
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core-001
-
批准号:10441002
-
项目类别:
-
资助金额:$108.26万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Project-002
-
批准号:10662366
-
项目类别:
-
资助金额:$50.91万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Project-003
-
批准号:10662367
-
项目类别:
-
资助金额:$25.27万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Administrative Core
-
批准号:10215779
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
国内基金
海外基金
登录
查看更多内容
SRSF3抑制剂SFI003逆转急性髓系白血病耐药性的功能与机制研究
-
批准号:2026JJ60275
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邢程
-
依托单位:
新型溶瘤性HPV治疗性疫苗MATV003的构建和药效学研究
-
批准号:JCZRMS202601746
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于JAK-STAT信号通路研究E003调控URSA的Th17/Treg免疫平衡的分子机制
-
批准号:82360318
-
项目类别:地区科学基金项目
-
资助金额:31.00万元
-
批准年份:2023
-
负责人:章志琴
-
依托单位:
噬菌体PaoP5编码蛋白Orf003通过FleQ抑制铜绿假单胞菌运动的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:王竞
-
依托单位:
HSP47抑制剂Col003抗血小板作用机制及其对大鼠脑缺血再灌注损伤影响的研究
-
批准号:82160236
-
项目类别:地区科学基金项目
-
资助金额:34万元
-
批准年份:2021
-
负责人:刘竞丽
-
依托单位:
缺血预处理诱导的tiRNA-Gly-GCC-003 在急性肾损伤中的保护作用及机制研究
-
批准号:2021JJ40954
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:张伟
-
依托单位:
PCSK9Qβ-003疫苗通过非LDLR代谢途径防治动脉粥样硬化
-
批准号:81900401
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:潘雅杰
-
依托单位:
PCSK9Qβ-003降脂疫苗抑制肾脏纤维化的机制研究
-
批准号:81900459
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:周彦兆
-
依托单位:
SNHG6-003调控外泌体促进肝癌细胞侵袭转移的分子机制
-
批准号:81872399
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2018
-
负责人:吴德华
-
依托单位:
砷氧化菌CRS003对稻田土壤中砷的形态转化和迁移的影响机制
-
批准号:21677033
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2016
-
负责人:杨桂娣
-
依托单位: